This substance was identified for action under the Chemicals Management Plan (CMP).
|CAS RN||Common name||DSL name||Final screening assessment||Conclusion on section 64 criteria||Follow-up activities|
|105-60-2||Caprolactam||2H-Azepin-2-one, hexahydro-||HTML||Does not meet||None planned at this time|
|February 18, 2023||Publication of the final screening assessment. The related notice was published in the Canada Gazette, Part I: Vol. 157, No. 7.|
|August 14, 2021||Publication and start of 60-day public comment period on the draft screening assessment. The related notice was published in the Canada Gazette, Part I: Vol. 155, No. 33.|
Report a problem or mistake on this page
- Date modified: